Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
D-Wave Announces Agreement to Acquire Quantum Circuits Inc., Establishing World’s Leading Quantum Computing Company
-
Main Street Announces New Portfolio Investment
-
Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance
-
PlusAI to Participate in Upcoming Investor Conference
-
WARNER BROS. DISCOVERY BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT AMENDED PARAMOUNT TENDER OFFER
-
CCMP Growth Appoints Managing Director Patrick McGrath to Its Investment Committee and Makes Four Additional Firmwide Promotions
-
Wabtec Secures $386 Million Order from New York’s MTA for New Locomotives
-
Automotive innovation through open collaboration: momentum builds around open source software as a key driver of efficiency and success
-
SmartMoving Acquires Remedy Payments to Bring Profit-focused Payments Into the Core Platform
-
Echo Water Launches 40 oz Hydrogen Tumbler for Smarter, All-Day Hydration
-
Aprio Expands in Pacific Northwest, Uniting Two Leading Oregon Firms - Delap LLP and Hoffman, Stewart & Schmidt, P.C.
-
Volastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy
-
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
-
Avient To Hold Fourth Quarter 2025 Conference Call
-
ABBYY and Desktop Imaging Fully Automate New Zealand Citizen Services and Enable Frontline Emergency Teams to Focus on Critical Work with Document AI
-
KKR and Oak Hill Capital Commit Nearly $2 Billion to Leading European Data Center Platform Global Technical Realty
-
Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Hyliion Holdings to Present at the 2026 Needham Growth Conference on January 16, 2026
-
BOARDWALK REIT PROVIDES OPERATIONAL AND CAPITAL ALLOCATION UPDATE AND ANNOUNCES TIMING OF FOURTH QUARTER RESULTS
-
Roblox Requires Users Worldwide to Age-Check to Access Chat
-
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
-
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
-
BitMart Exchange Announces Partnership with Hit TV-Reality Show CryptoKnights for Season 2
-
Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week
-
Barrick to Report Full Year and Fourth Quarter 2025 Results on February 5
-
BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs
-
PAT TILLMAN FOUNDATION ANNOUNCES 22nd ANNUAL PAT’S RUN, PRESENTED BY TEKSYSTEMS
-
Impact Analytics named a Major Player in the 2025–2026 IDC MarketScape for Worldwide Retail Price Optimization Solutions Vendor Assessment
-
CECO Environmental Announces Upcoming Investor Conference
-
Rumble and Tether Launch Crypto Wallet for Creator Economy
-
Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.
-
Dmitry Shubov Supports Southeast Asian Legal Tech Startups in Securing IP Protection for U.S. Market Entry and Success
-
Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
OTC Markets Group Welcomes Bora Pharmaceuticals Co., Ltd. to OTCQX
-
OTC Markets Group Welcomes FUTURE FUELS INC to OTCQX
-
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence
-
Dividend Declaration
-
JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist
-
Datavault AI Announces Experiential Marketing Collaboration with New York’s Fifth Avenue Luxury Retailer Riflessi to Enable Sponsored Immersive 3D Digital Twins of Inventory with ADIO(R) and DVHOLO(
-
Kalo Gold Launches Major District-Scale Airborne Geophysics And Lidar Survey at Vatu Aurum Project, Fiji
-
Future Fuels Graduates to OTCQX(R) Best Market
-
Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing
-
New Found Gold Celebrates Milestone Year: Transformation to an Emerging Canadian Gold Producer
-
CRYOVAC® Brand Food Packaging Marks 85 Years of Innovation, Performance and Customer Service
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Taylor Morrison Announces Date for Fourth Quarter 2025 Earnings Release and Webcast Conference Call
-
Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China
-
Timken Announces Strategic Leadership Appointments to Accelerate Profitable Growth
-
QIXZOCV Introduce the Future of Digital Signage - The Seamlessly Spliceable LED Poster Screen
